U.S. Markets closed

Johnson & Johnson Accepts Sale of Its LifeScan Business

Sarah Collins
Johnson & Johnson Accepts Sale of Its LifeScan Business

On June 12, Johnson & Johnson (JNJ) announced it had accepted a $2.1 billion offer for the sale of its LifeScan business, which manufactures blood glucose monitoring devices and OneTouch products, from private equity company Platinum Equity. On June 12, JNJ stock fell ~0.42% following the deal announcement.